Ï㽶ÊÓƵ

Hematology & Oncology Presentations

Thrombosis Management

Dr. Vicky Tagalakis

Ìý

Dr. Tagalakis is the Physician-in-Chief, Jewish General Hospital, CCOMTL Associate Chair, Department of Medicine, Ï㽶ÊÓƵ Research Scientist, Centre of Epidemiology and Community of Studies, Lady Davis Institute for Medical Research, Jewish General Hospital.

Ìý

Ìý

Learning Objectives:

  1. Prescribe direct oral anticoagulants (DOACs) to treat venous thromboembolism (VTE)
  2. Have a better understanding of using DOACs in special circumstances
  3. Have an approach to determining how long to treat patients with VTE

    A Case Based Approach to the Interpretation of the CBCÌý

Dr. Margaret Warner

Ìý

Dr. Warner is an Associate Professor of Medicine (Division of Hematology), chief hematologist at laboratories OPTILAB, chief of the Hemophilia Treatment Centre of the Ï㽶ÊÓƵ Health Centre and MUHC hemoglobinopathies clinic.

Ìý

Ìý

Learning Objectives:

  1. How we generate a CBC
  2. Quality assurance both pre-analytic and analytic on a daily basis
  3. Physiologic causes of variation in blood counts

    Cancer Genetics: When to Refer

Dr. Tania Cruz-MarinoDr. Tania Cruz-Marino received her medical degree in Cuba from Holguin Medical University and she completed her Medical Genetics residency program as well as her Ph.D. studies at the Havana Superior Institute of Medical Sciences. She headed the Predictive Diagnosis Department at the Cuban national centre for research and rehabilitation of hereditary ataxias and she was an instructor, assistant and associate professor at the Holguin Medical University. Dr. Cruz-Marino holds a specialist certificate in Medical Genetics granted by the Collège des Médecins du Québec. Being the first full-time medical geneticist in the Saguenay, she has contributed to the development of the Medical Genetics Service in that region. She has a particular interest in cancer genetics and has authored or co-authored 38 articles published in peer-reviewed journals.

Learning Objectives:

  1. Determine which patients answer to referral criteria for evaluation in Cancer Genetics
  2. Interpret the possible testing results and distinguish proper management accordingly
  3. Offer counselling, education and support to individuals affected or at-risk for hereditary cancer predisposition syndromes

    Use of Tumour Markers and General Cancer Work-Up

Dr. Parvaneh Fallah

Ìý

Dr. Fallah is a medical oncologist at the Jewish General Hospital with clinical/research focus on breast and genitourinary malignancies.

Ìý

Ìý

Ìý

Learning Objectives:

  1. Be able to know the screening tests and schedule for the 4 most common malignancies
  2. Be able to know theÌýuse of tumour markers for screening and cancer survivor follow ups
  3. Be able to know the surveillance for the 4 most common malignancies

Ìý

McGill Medicine CPD Office Fb View Content

Back to top